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Abstract
Cholera toxin (CT) stimulated DNA synthesis by low-density primary cultures of adult rat type II pneumocytes (T2P) in a
dose-dependent manner, either in the presence or the absence of serum. In the presence of 1% rat serum, 1 Wg/ml CT also
stimulated a 50% increase in cell number over 8 days of incubation (P6 0.01); this was in addition to a 2-fold increase in cell
number induced by the serum alone (P6 0.05). The same dose of CT also elevated intracellular cAMP and the total activity
of protein kinase A (both P6 0.01), suggesting toxin stimulation of T2P proliferation by a cAMP-dependent mechanism.
However, the effect of CT on DNA synthesis could not be mimicked by 8-bromoadenosine 3P :5P-cyclic monophosphate
(8-bromo-cAMP), nor by N6,2P-O-dibutyryladenosine 3P :5P-cyclic monophosphate (dibutyryl-cAMP), each tested over a
wide range of concentrations. L-Isoproterenol stimulated surfactant secretion by over 5-fold (P6 0.01), but neither the
L-agonist, forskolin nor 3-isobutyl-1-methylxanthine had any significant effect on DNA synthesis. The purified B-subunit of
CT stimulated DNA synthesis to the same degree as did the holotoxin, either in the presence or the absence of rat serum. In
contrast, the purified A-subunit had no significant effect. These data suggest that cholera toxin stimulates type II pneumocyte
proliferation through a mechanism that is independent of cAMP, protein kinase A and toxin-catalyzed ADP-
ribosylation. ß 1998 Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Proliferation and di¡erentiation of type II pulmo-
nary alveolar epithelial cells is believed to be respon-
sible for normal turnover of the alveolar epithelium
and alveolar repair after lung injury [1]. Various
forms of lung injury result in the proliferation of
type II cells, which are believed to replenish both
the type I and type II alveolar epithelial cell popula-
tions [2,3]. The rate of alveolar repair by this mech-
anism is an important determinant in the develop-
ment of pulmonary ¢brosis [4], and uncontrolled
proliferation of type II pneumocytes may lead to
lung carcinoma [5]. Thus, an understanding of the
regulation of type II cell proliferation is crucial to
the de¢nition of normal and abnormal lung injury/
repair mechanisms. Further, elucidation of signaling
pathways involved in both positive and negative con-
trol of this process will provide a foundation from
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which to design therapeutic strategies for the manip-
ulation of alveolar repair.
A high percentage of chemically induced mouse
lung tumors are now known to derive directly from
type II pneumocytes [5,6]. Studies of mouse lung
tumorigenesis have thus provided important insights
into the control of type II cell proliferation within
these tumors. Glucocorticoids are known to inhibit
the genesis of urethane-induced tumors, as well as
the proliferation of tumor-derived type II cell lines;
the inhibitory action is believed to be mediated by
protein kinase C [7]. In studies of tumorigenic type II
cell lines [8], both isoforms of the regulatory subunit
of protein kinase A were found to be less susceptible
to activation by cAMP, as a result of either de-
creased expression (RI subunit) or altered state of
phosphorylation (RII). These and other observations
have led to the hypothesis that the cAMP/protein
kinase A-mediated pathway is inhibitory to the
growth of type II cell-derived mouse lung tumors
[8,9].
In related work, a number of laboratories have
adopted the model of type II cells in primary culture
to investigate the in£uence of extracellular matrix
components [10,11], puri¢ed polypeptide growth fac-
tors [12,13] and other growth-regulatory substances
on the proliferation of these cells. The most potent of
these appear to be factors which act through tyrosine
kinase type receptors, such as those for epidermal
growth factor [14], insulin-like growth factor I [15]
and the ¢broblast growth factors [12]. DNA synthe-
sis by primary adult rat type II cells is also stimu-
lated by cholera toxin [13], which was shown earlier
[16] to stimulate surfactant secretion in primary cul-
tures by a cAMP-dependent mechanism. Together,
these observations suggested a stimulatory role for
cAMP/protein kinase A in the proliferation of pri-
mary type II cells, in contrast to the type II cells
within chemically induced mouse lung tumors. As a
test of that hypothesis, we studied the in£uence of
membrane-permeable cAMP analogs and agents ca-
pable of elevating intracellular cAMP on type II cell
proliferation in primary culture. In this report we
demonstrate that cAMP has no apparent in£uence
on the proliferation of primary type II cells, and
conclude that the stimulatory action of cholera toxin
is mediated through a cAMP-independent mecha-
nism.
2. Materials and methods
2.1. Animals and reagents
Male Sprague-Dawley rats (200 g) were obtained
from Charles River Laboratories and were housed in
the Department of Comparative Medicine, the Mil-
ton S. Hershey Medical Center as described previ-
ously [17]. Materials for cell isolation and culture
were purchased from sources described elsewhere
[17]. Cholera holotoxin (type Inaba B) was obtained
from Calbiochem (La Jolla, CA). Puri¢ed A-subunit
and B-subunit of cholera toxin, forskolin, L-isopro-
terenol and 3-isobutyl-1-methylxanthine (IBMX)
were obtained from Sigma (St. Louis, MO), as
were 8-bromoadenosine 3P :5P-cyclic monophosphate
(8-bromo-cAMP), N6,2P-O-dibutyryladenosine 3P :5P-
cyclic monophosphate (dibutyryl-cAMP), and deoxy-
ribonuclease I (DNase I). Cell dissociation solution
(PET) was purchased from Upstate Biotechnology
(Lake Placid, NY). Anti-vimentin monoclonal anti-
body (clone V9), monoclonal antibody AE3, FITC-
and rhodamine-conjugated anti-mouse IgG and
5-bromo-2-deoxyuridine were purchased from
Boehringer Mannheim (Indianapolis, IN). All other
chemicals were of reagent grade, or were purchased
from sources described earlier.
2.2. Pneumocyte isolation and culture
Type II pneumocytes were isolated by a protocol
described previously [17]. Brie£y, rat lungs were per-
fused in situ to remove blood and were then excised.
The isolated lungs were instilled three consecutive
times with 10 ml of a mixture of elastase (30 U/ml,
ICN Nutritional Biochemicals, Cleveland, OH) and
0.05% BaSO4 for a total of 20 min incubation at
37‡C. The lungs were then reinstilled with 10 ml of
a mixture of 50% fetal bovine serum (FBS) and
DNase I (240 Wg/ml) to inhibit the elastase reaction.
After 5 min at 20‡C, the lobes were freed of large
airways and other tissues and minced to produce
1 mm2 fragments. The minces were agitated for
10 min at 20‡C and ¢ltered through 160 Wm nylon
mesh. The resulting suspension was centrifuged for
6 min at 315Ug, and the cell pellet resuspended in
Dulbecco’s modi¢ed Eagle’s medium (DMEM) and
layered over a 2-step gradient (density = 1.04 over
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1.08) of Percoll in DMEM. The gradient was centri-
fuged at 400Ug for 20 min at 4‡C, and a fraction of
cells enriched in type II pneumocytes was recovered
from the 1.04^1.08 interface. The cells were washed
once, resuspended in DMEM plus 10% FCS and
plated at 3^4U106/ml for 30 min to remove macro-
phages [18]. Depending on experimental requirement,
non-adherent cells were either recovered directly or
plated on tissue culture plastic at the indicated den-
sities in DMEM plus 10% FBS. After 24 h at 37‡C
(referred to as culture day 1), the adherent cells were
washed and the medium was replaced with RPMI
1640 supplemented with the indicated sera. The me-
dium was changed every 48 h in experiments of lon-
ger than 72 h duration. Rat sera were collected from
the same animals as those used for cell culture by
cardiac puncture immediately before in situ perfusion
of the lungs. On culture day 1, adherent type II cells
were identi¢ed as more than 95% pure by positive
acridine orange staining [18] and immunoreactivity
to monoclonal AE3, as well as negative anti-vimentin
immunoreactivity [19]. Prior to immunocytochemis-
try, adherent cells were ¢xed with 70% ethanol at
320‡C. The cells were washed and then incubated
with a solution of 1% bovine serum albumin (BSA)
for 1 h at 37‡C. Monoclonal antibodies were then
applied for 1 h at 37‡C at 1/100 dilution in
1%BSA/PBS. Secondary antibodies consisting of
rhodamine-conjugated anti-mouse IgG were applied
for 30 min at 37‡C.
2.3. Toxin and agonist incubations
Cell incubations with cholera toxin were con-
ducted essentially as described previously [16]. Before
application to cultured cells, cholera holotoxin or
puri¢ed subunits were activated at 37‡C for 10 min
in the presence of 5 mM dithiothreitol (DTT). Cul-
ture media for all toxin and control incubations
therefore contained 100 WM DTT, which had no ef-
fect on DNA synthesis (not shown). Dimethylsulfox-
ide (DMSO) was used as the diluent for forskolin,
dibutyryl-cAMP and IBMX; similarly, DMSO had
no e¡ect when included in control incubations in the
absence of agonist. All incubations with toxin or
agonists were conducted by the same general design:
type II cells were cultured for a total of 72 h; toxin,
agonist (or vehicle) were added to the medium after
24 h, and labeled thymidine was added after 48 h. At
72 h, the cells were washed and harvested with tri-
chloroacetic acid and sodium hydroxide for radioac-
tivity and/or protein determinations as described ear-
lier [16]. Alternatively, cells were harvested with
ethanol for isolation of disaturated phosphatidylcho-
line [20] or with 1 N HCl for determination of intra-
cellular cAMP [16]. For determination of total pro-
tein kinase A activity, cells were harvested after 1 h
of incubation by scraping into cold PBS containing
1 WM phenylmethylsulfonyl £uoride (PMSF). The
resulting cell suspension was then sonicated at 0‡C
for 60 s with a Branson sonicator and the sonicates
were stored at 320‡C.
2.4. Assays and general methods
Cell number was measured by £ow cytometric
counting of cell nuclei prepared from adherent cells
as described earlier [19]; the e¡ect of cholera toxin
on cell number was determined after 8 days of incu-
bation. Rates of cell cycle progression were obtained
by £ow cytometric analyses of the relative movement
(RM) of 5-bromo-2-deoxyuridine (BrdUrd)-positive
cells over 5 h of in vitro pulse-labeling as described
earlier [22]. Brie£y, the cells are pulse-labeled with
10 WM BrdUrd in the indicated culture media for
1 h. At 2.5, 5 and 7.5 h after the end of the pulse
period, the cells are quickly trypsinized from the cul-
ture surface, ¢xed in 70% ethanol and prepared for
bivariate FACS analysis of DNA content versus
BrdUrd content with propidium iodide and anti-
BrdUrd-£uorescein as described earlier (DNAdist).
The rates of S-phase and G2/M-phase transit are
calculated from the relative movement (RM) of the
BrdUrd-positive cell population with respect to the
BrdUrd-negative diploid (G0/G1) and tetraploid (G2/
M) subsets over the 7.5 h post-pulse interval. Time-
dependent movement of the BrdUrd-positive popu-
lation toward the G2/M position indicates replicative
DNA synthesis, whereas BrdUrd incorporation with-
out movement indicates DNA repair. Similarly, a
time-dependent disappearance of BrdUrd-positive
tetraploid cells together with a reciprocal appearance
of BrdUrd-positive diploid cells indicates mitoses of
the BrdUrd-positive cohort. The slopes and x-inter-
cepts of lines plotted through the 2.5, 5 and 7.5 h
time points yield rate information (for details, see
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[22]). Cell cycle transit data were obtained on day 4
of primary culture.
Cellular protein and incorporated radioactivity
were assessed by standard methods as described pre-
viously [17]. Lactate dehydrogenase was measured by
a spectrophotometric method [16] applied to aliquots
of cell-free medium collected over the last 48 h of
culture. Total protein kinase A activity was measured
in cell sonicates with a peptide pseudosubstrate assay
(Upstate Biotechnology, Lake Placid, NY) per-
formed in the presence of excess exogenous cAMP.
Intracellular cAMP was assessed with a colorimetric
immunoassay kit (Advanced Magnetics, Cambridge,
MA) applied to neutralized 1 N hydrochloric acid
extracts of adherent cells [16]. Surfactant secretion
was measured as described earlier [16] as the percent-
age of total cellular disaturated phosphatidylcholine
released from prelabeled cells over a 90 min incuba-
tion in the presence of agonist or vehicle.
3. Results
3.1. Type II cell proliferation in low-density primary
culture
Previous e¡orts to induce type II pneumocyte pro-
liferation in vitro have been unsuccessful, resulting in
stimulation of DNA synthesis followed by cell cycle
block in S-phase [21] or G2/M-phases [12,22]. In the
present study, we therefore employed a low-density
primary culture system which supports cell division.
As shown in Fig. 1 (bottom panel), adult rat type II
cells increased in number by 3-fold over 8 days in
culture in the presence of 1.0% rat serum, provided
that the cells were cultured at a density no greater
than 0.2U105/cm2. The observed increases in cell
number were not signi¢cantly in£uenced by changes
in the number of binucleated cells under these con-
ditions (see Section 3.2). Medium supplemented with
1.0% fetal bovine serum (FBS) had no e¡ect on cell
number, despite the fact that this medium could
stimulate DNA synthesis (not shown).
Cells cultured at a density just 3-fold higher (Fig.
1, upper panel) did not increase in number, even in
the presence of rat serum, and despite the fact that
they were only 50^60% con£uent after 8 days in cul-
ture (not shown). Type II cells cultured at the lower
density began to form colonies at 2^3 days after the
addition of rat serum and became con£uent after
9^10 days. At day 2 after isolation, more than 95%
of the cells contained inclusion bodies which stained
positively classical lamellar body stains (see Section
2). At con£uence, more than 90% of the cells reacted
positively with monoclonal antibodies to cytokera-
tins 7 and 8, but negatively with monoclonal anti-
bodies to vimentin (not shown), con¢rming the epi-
thelial origin of the cells which proliferated in
response to the rat serum. All subsequent experi-
Fig. 1. Primary adult rat type II pneumocytes cultured at low
density proliferate in response to normal rat serum. (Top panel)
Type II cells plated at 0.6U105/cm2 fail to increase in number
despite exposure to rat serum or fetal bovine serum (FBS).
(Bottom panel) Cells cultured at lower density (0.2U105/cm2)
increase 3-fold in number over 8 days in culture in the presence
of normal rat serum, but not in the presence of FBS. Cells
were isolated and plated on tissue culture plastic as described in
Section 2; all data points represent the mean þ S.E.M. of at
least three determinations in two separate experiments.
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ments were performed with cells cultured at the low-
er density of 0.2U105/cm2.
3.2. Stimulation of type II cell DNA synthesis and cell
division by cholera toxin
Cholera holotoxin stimulated type II cell DNA
synthesis in a dose dependent manner, either in the
presence or absence of rat serum (Fig. 2, left panel).
Only the highest toxin dose (10 Wg/ml) induced mild
cytotoxicity after 24 h of cell exposure (see Section
2); doses one and two orders of magnitude lower
were capable of stimulating DNA synthesis by about
2-fold. At the subtoxic dose of 1.0 Wg/ml, cholera
toxin also induced an increase in type II cell number,
provided that it was applied in the presence of rat
serum (Fig. 2, right panel). In the absence of rat
serum, the toxin had no e¡ect on cell number despite
the ability to stimulate thymidine incorporation at
the same concentration (left panel). As shown in Ta-
ble 1, £ow cytokinetic analyses of bromodeoxyuri-
dine incorporation (BrdUrd, see Section 2) indicated
that cholera toxin by itself (+cholera, serum-free)
increased by 10-fold the percentage of cells which
incorporated the thymidine analog. However, the
BrdUrd-positive cells without serum exhibited no de-
tectable progression through S- or G2/M-phases over
time (Table 1, denoted NP), suggesting that toxin-
stimulated BrdUrd incorporation may have resulted
from DNA repair or from aborted initiation of rep-
lication. In contrast, the same dose of toxin applied
in the presence of serum induced a 5-fold decrease in
Fig. 2. Cholera toxin stimulates type II pneumocyte DNA synthesis in a dose-dependent manner. (Left panel) In the presence or ab-
sence of rat serum, cholera holotoxin stimulates thymidine incorporation into acid-precipitable material. Type II cells were cultured at
low density for 72 h; toxin (or vehicle) was added to the medium after 24 h, and labeled thymidine was added after 48 h. At 72 h,
the cells were washed and harvested for radioactivity and protein determinations as described in Section 2. Lactate dehydrogenase re-
lease was una¡ected except at the highest dose of toxin. Values represent the mean þ S.E.M. of at least three determinations in two
separate experiments; *P6 0.05 compared to no toxin by Analysis of Variance and Dunnett’s test. (Right panel) Normal rat serum
stimulated a 2-fold increase in type II cell number when applied over 8 days in low-density primary culture (*P6 0.05). The subtoxic
dose of 1 Wg/ml cholera toxin induced a further increase in cell number in the presence of serum (**P6 0.01 vs. serum alone), but
had no e¡ect on cell number in the absence of rat serum. Preparation of toxin and counting of cells are described in Section 2.
Table 1
E¡ects of cholera toxin on cell cycle progression by type II cells
in low-density primary culture
S-phasea (%) TbS (h) TG2=M (h)
Serum-free
No toxin 0.5 þ 0.4 NPc NP
+cholera (1 Wg/ml) 4.2 þ 0.5 NP NP
1% rat serum
No toxin 4.3 þ 0.7 12.0 10.3
+cholera (1 Wg/ml) 7.7 þ 1.5 7.9 2.1
aDetermined as % BrdUrd-positive by £ow cytometry; values
are means þ S.E.M. of three determinations.
bCell cycle transit times were determined by £ow cytokinetic as-
say as described earlier [22]; TS, duration of S-phase; TG2=M,
duration of G2/M-phases.
cNP, no cell cycle progression detectable.
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the G2/M-phase transit time (TG2=M, +cholera) com-
pared to transit induced by serum alone. The faster
rate of cell cycle transit was re£ected in the lower
percentage of binucleated cells (Table 2) observed
in the presence of toxin and serum (although these
were not quite signi¢cant statistically).
3.3. Stimulation of type II cell adenylate cyclase by
cholera toxin
In earlier work with type II cells exposed to chol-
era toxin in high density culture [16], we identi¢ed
substrates for toxin-dependent ADP-ribosylation in
type II cell membrane fractions. On the basis of sen-
sitivity toward GTP analogs and their apparent mo-
lecular weights, two of these substrates were pre-
sumed to be the two isoforms of the stimulatory
G-protein GsK. Under the culture conditions em-
ployed in this study (Fig. 3), exposure of type II cells
Fig. 3. Cholera toxin elevates intracellular cAMP and total pro-
tein kinase A activity in primary type II cells. (Top panel) Type
II cells cultured at low density for 24 h (+rat serum) were ex-
posed to a subtoxic dose of cholera holotoxin (1 Wg/ml). Five
minutes later, cells were harvested with 1 N HCl for determina-
tion of intracellular cAMP as described in Section 2. (Bottom
panel) Type II cells were cultured and exposed to toxin as de-
scribed in the panel above. One hour after exposure to toxin,
the cells were harvested by scraping and sonication for determi-
nation of total protein kinase A activity as described in Section
2. All values represent the mean þ S.E.M. of at least four obser-
vations; by Student’s t-test, values from toxin-treated cells are
signi¢cantly di¡erent from the control at P6 0.01.
Fig. 4. Cyclic AMP analogs have no e¡ect on type II cell DNA
synthesis in low-density primary culture. (A) Type II cells were
incubated with the indicated concentrations of 8-bromo-cAMP
in the presence or absence of 1.0% normal rat serum. Cells
were cultured at low density for 72 h; analog (or vehicle) was
added to the medium after 24 h, and labeled thymidine was
added after 48 h. At 72 h, the cells were washed and harvested
as in the legend to Fig. 2. (B) Type II cells were incubated with
dibutyryl-cAMP in the same manner as that described in A.
Neither analog signi¢cantly in£uenced DNA synthesis at any
concentration; all values represent the mean þ S.E.M. of at least
four observations.
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to the subtoxic dose of cholera toxin (+rat serum)
elevated intracellular cAMP (top panel), presumably
as a result of activation of adenylate cyclase through
the ADP-ribosylation of GsK isoforms [23]. One
hour after exposure to cholera toxin, the same cells
exhibited a 3-fold increase in the total activity of
protein kinase A (bottom panel), consistent with
the premise that the subtoxic dose of toxin was ca-
pable of eliciting a protein kinase A-dependent sig-
naling cascade in these cells (see Fig. 5).
3.4. Cyclic AMP independence of the cholera toxin
e¡ect
The ability of cholera toxin to elevate intracellular
cAMP and total protein kinase A activity suggested
that the toxin-dependent stimulation of type II cell
proliferation was a cAMP-mediated mechanism.
However, neither 8-bromo-cAMP (Fig. 4A) nor N6-
O2-dibutyryl-cAMP (Fig. 4B) were capable of stim-
ulating DNA synthesis by type II cells in low-density
primary culture, either in the presence or absence of
rat serum. Not only did cAMP analogs fail to stim-
ulate type II cell DNA synthesis, but so did forskolin
(Fig. 5, left panel), isobutylmethylxanthine (IBMX,
middle panel), and isoproterenol (right panel), re-
gardless of whether these agents were applied in the
presence or absence of rat serum. As shown in the
inset (right panel), 1035 M isoproterenol was capable
of stimulating surfactant secretion by over 5-fold in
replicate wells of the low-density cell preparations,
but the same concentration of the L-agonist had no
e¡ect on DNA synthesis. Although the 1034 M iso-
proterenol was signi¢cantly inhibitory for DNA syn-
thesis, this dose was also mildly cytotoxic over a 24 h
incubation (not shown). Forskolin at 1034 M in-
duced a potent and sustained elevation of intracellu-
lar cAMP for up to 18 h of primary culture (Fig. 6),
but had no e¡ect on DNA synthesis (Fig. 5).
Fig. 5. Agents capable of elevating intracellular cAMP have no e¡ect on DNA synthesis by type II cells in low-density primary cul-
ture. Type II cells were incubated with the indicated concentrations of forskolin (left panel), isobutylmethylxanthine (IBMX, middle
panel) or isoproterenol (right panel) in the presence or absence of rat serum. Cells were preincubated with each agent for 24 h before
measurement of DNA synthesis over the subsequent 24 h as in Figs. 3 and 4. The highest concentration of isoproterenol (1034 M) in-
duced cytotoxicity as measured by lactate dehydrogenase release (see Section 2); all other values were not signi¢cantly di¡erent from
the zero dosage. (Inset) Incubation of type II cells with 1035 M isoproterenol (+ISO) for 1.5 h stimulated secretion of pulmonary sur-
factant by 5-fold; by Student’s t-test, P6 0.01 compared to control (CTL). Secretion was measured as the percentage of total cellular
disaturated phosphatidylcholine released per hour; all values represent the mean þ S.E.M. of at least four observations.
Table 2
Binucleated type II pneumocytes in low-density culture
Treatment % of total
Serum-free (SF) 4.88+0.58
+rat serum (RS) 4.00+0.53
+toxin (SF) 3.88+0.30
+toxin (+RS) 3.00+0.42
Data are the mean þ S.E.M. of eight observations from two
separate experiments. Values were obtained at 8 days of
primary culture under the same low-density conditions as in
Fig. 2.
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3.5. Independence of cholera toxin action on ADP-
ribosylation
In a functional sense, the cholera holotoxin con-
sists of two subunits; the A-subunit, which contains
the ADP-ribosyltransferase activity, and the B-subu-
nit, which has no known enzymatic activity, but fa-
cilitates binding of the holotoxin to the cell surface
[23]. As shown in Fig. 7, the puri¢ed cholera toxin B-
subunit alone was capable of stimulating DNA syn-
thesis by type II cells in low-density culture, either in
the presence or absence of rat serum (left panel). In
the presence of serum, the B-subunit stimulated
DNA synthesis to the same degree as did the holo-
toxin; in serum-free media, the B-subunit was also
stimulatory, but it was roughly 10-fold less potent. In
contrast, the puri¢ed A-subunit had no signi¢cant
e¡ect on type II cell DNA synthesis, either in the
presence or the absence of serum (right panel).
4. Discussion
The role of intracellular cAMP and protein kinase
A in the regulation of cell proliferation remains con-
troversial, largely because of the fact that cAMP is
inhibitory for the proliferation of some cells and
stimulatory for others. Agents capable of elevating
or mimicking intracellular cAMP can inhibit the pro-
liferation of ¢broblast cell lines, T-cells and neuro-
blastoma cells, for example [24], but can potently
Fig. 7. Puri¢ed cholera toxin B-subunit stimulates DNA synthesis by type II cells in the presence or absence of rat serum. Low-den-
sity cultures of type II cells were incubated with the indicated concentrations of puri¢ed cholera toxin B-subunit (left panel) or puri-
¢ed A-subunit (right panel) in the presence or absence of rat serum. Cells were preincubated with each subunit for 24 h before meas-
urement of DNA synthesis over the subsequent 24 h as in Figs. 2^4. All values represent the mean þ S.E.M. of at least four
observations; *P6 0.01 and **P6 0.05 compared to the zero dose by Analysis of Variance and Dunnett’s test. The puri¢ed A-subunit
had no signi¢cant e¡ect either in the presence or absence of rat serum.
Fig. 6. Forskolin induces sustained elevation of cAMP in pri-
mary type II pneumocytes. Type II cells at 2 days of primary
culture were incubated with 1034 M forskolin for the indicated
number of hours and harvested as described in Section 2. Intra-
cellular cAMP was measured by EIA. *P6 0.05; **P6 0.01
compared to time zero by Dunnett’s test. Values are the
mean þ S.E.M.; where not visible, error bars fall within sym-
bols.
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stimulate the proliferation of well-di¡erentiated epi-
thelial cells such as the parotid cell [25] or thyrocyte
[26]. In these cell types, the stimulatory e¡ect of
cAMP is elicited without phosphorylation of the
42^44 kDa mitogen-activated protein kinases [27],
which are induced by growth factors which act
through receptors coupled to protein tyrosine kinases
(PTK) and/or protein kinase C (PKC). Further,
those growth factors invoke a pattern of protein
phosphorylation that is distinct from that induced
by cAMP [27]. Thus, the actions of cAMP on cell
proliferation are likely exerted at points downstream
from the signal transduction pathways activated by
PTK- and PKC-mediated growth factors. Consistent
with these observations, recent evidence from rat ¢-
broblast cell lines suggests that cAMP alters the in-
teraction between the protein kinase raf-1 and the
activated form of ras, presumably through altera-
tions in the phosphorylation state of raf-1 [28,29].
The relevance of these ¢ndings with respect to the
variability in cAMP action on cell proliferation re-
mains to be determined.
An inhibitory role for cAMP in the proliferation
of type II pneumocytes was suggested by the work of
Lange-Carter et al. [8], who have identi¢ed altera-
tions in both isoforms of the regulatory subunit of
protein kinase A within tumorigenic cell lines of type
II cell origin. In some cell lines, the amount of the RI
isoform is reduced and the extent of phosphorylation
of the RII subunit is increased; these alterations are
consistent with reduced susceptibility of the protein
kinase A holoenzyme to activation by the cyclic nu-
cleotide [8]. These and other observations have led to
the hypothesis that the growth of type II cell-derived
tumors is less resistant to the inhibitory action of
cAMP on pneumocyte proliferation. To our knowl-
edge, the direct e¡ect of cAMP analogs or cAMP-
dependent agonists on the proliferation of type II
cells in vivo or in vitro has not been investigated.
Indirect evidence consistent with a stimulatory role
for cAMP in the proliferation of primary type II
pneumocytes was ¢rst provided by Leslie et al. [13],
who found that cholera toxin stimulated DNA syn-
thesis by adult rat type II cells cultured at high den-
sity. Under the conditions of that study, cholera tox-
in stimulated DNA synthesis but did not induce
increases in cell number. Later work by the same
group [12] found that type II cells stimulated with
¢broblast growth factors (FGFs) undergo increases
in DNA synthesis accompanied by a large increase in
the number of binucleated cells. In the present study,
the toxin by itself stimulated DNA synthesis by cells
with S-phase DNA content, but without cell progres-
sion through S- or G2/M-phases, suggesting induc-
tion of DNA repair or initiation of DNA replication
that was aborted in the absence of additional growth
factors. To our knowledge, such an e¡ect of cholera
toxin has not been reported earlier, and may be
unique to type II cells. When contrasted with the
studies of high density cultures by Leslie et al. [13],
the fact that the addition of serum at lower cell den-
sities permitted cell division without the accumula-
tion of binucleated cells suggests that traverse of G2/
M-phases in type II cells is particularly sensitive to
cell density. These ¢ndings are consistent with our
earlier investigations of the type II cell cycle in vivo
and in short-term primary culture [22].
Our presumption that the stimulatory e¡ect of
cholera toxin was mediated by cAMP was consistent
with earlier observations from this laboratory [16],
which demonstrated that type II cells possess mem-
brane-associated cholera toxin substrates which were
functional in L-agonist-stimulated surfactant secre-
tion. Those studies were conducted with high-density
primary cultures; in the present work it was found
that the ability of cholera toxin or isoproterenol to
elevate intracellular cAMP or surfactant secretion,
respectively, were maintained in low-density primary
cultures as well. Under these conditions, the failure
of cAMP analogs and cAMP-elevating compounds
to induce DNA synthesis provide strong evidence
of the cAMP independence of the cholera toxin e¡ect
on type II cell proliferation.
Cholera toxin action independent of the cAMP-
mediated pathway has been described; the toxin in-
hibits chemotaxis of the RAW264 mouse macro-
phage cell line [30], enhances the expression of
MHC class II molecules by mouse B cells [31] and
induces the expression of the immediate-early re-
sponse gene JE [32], all by cAMP-independent mech-
anisms. In addition, cAMP-independent toxin e¡ects
on cell proliferation have been implicated in several
experimental systems. The cholera holotoxin inhibits
the growth of human small-cell lung carcinoma cell
lines [33], an e¡ect that could not be reproduced with
forskolin or cAMP analogs. Further, the puri¢ed
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B-subunit of cholera toxin inhibited mitogen-stimu-
lated B-cell proliferation [31], but enhanced EGF-in-
duced DNA synthesis in primary cultures of rat hep-
atocytes [34]. The B-subunit of cholera toxin
facilitates binding of the cholera holotoxin to the
cell surface via the cholera toxin receptor, the GM1
ganglioside [23], and the A1-subunit contains the
ADP-ribosyltransferase activity. Thus, cholera toxin
e¡ects that are reproducible with puri¢ed B-subunit,
but not with puri¢ed A-subunit, are independent of
the activation of adenylate cyclase through ADP-ri-
bosylation of GsK.
At present, the mechanism by which the puri¢ed
B-subunit of cholera toxin stimulates cell prolifera-
tion is unclear. The function of the B-subunit within
the holotoxin appears to be the aggregation of mem-
brane-associated GM1 gangliosides to form a pore,
through which the A-subunit can gain access into
the cell [23]. Evidence from neuronal cells [35], rat
lymphocytes [36] and 3T3 ¢broblasts [37] suggests
that the B-subunit-GM1 ganglioside complex modu-
lates a rapid rise in intracellular free calcium, which
may be involved in the mitogenic response of some
cells to the isolated B-subunit. However, other evi-
dence suggests that the rise in calcium may not be
su⁄cient to invoke mitogenesis [38]. These observa-
tions are consistent with the ¢nding that calcium
ionophores can induce expression of c-myc and
c-fos, but cannot induce DNA synthesis in the ab-
sence of other growth factors [39]. Interestingly, the
isolated B-subunit of cholera toxin inhibits the pro-
liferation of ras-transformed NIH3T3 cells, but stim-
ulates that of quiescent NIH3T3 cells [40]. These
¢ndings are paralleled by the observation that chol-
era toxin inhibits the proliferation of human lung
carcinoma cell lines [33], but as shown in this report,
stimulates the proliferation of primary type II cells.
The signi¢cance of these ¢ndings will be interesting
topics for future inquiry.
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